1,254
Views
0
CrossRef citations to date
0
Altmetric
Articles

“Doing Good” in U.S. Cancer Genomics? Valuation practices across the boundaries of research and care in rural community oncology

, , , &
Pages 254-283 | Received 20 May 2021, Accepted 30 May 2022, Published online: 12 Jul 2022

References

  • Ackerman, Sara L., Katherine Weatherford Darling, Sandra Soo-Jin Lee, Robert A. Hiatt, and Janet K. Shim. 2016. “Accounting for Complexity Gene-Environment Interaction Research and the Moral Economy of Quantification.” Science, Technology, & Human Values 41 (2): 194–218.
  • Adams, V., M. Murphy, and A. E. Clarke. 2009. “Anticipation: Technoscience, Life, Affect, Temporality.” Subjectivity 28: 246–265.
  • Anderson, Eric C., John DiPalazzo, Emily Edelman, Petra Helbig, Kate Reed, Susan Miesfeldt, Christian Thomas, et al. 2021. “Patients’ Expectations of Benefits From Large-Panel Genomic Tumor Testing in Rural Community Oncology Practices.” JCO Precision Oncology 5 (November): 1554–1562. doi:10.1200/PO.21.00235.
  • Anderson, Eric C., Alexandra C. Hinton, Christine W. Lary, Anny T. H. R. Fenton, Andrey Antov, Emily Edelman, Petra Helbig, et al. 2021b. “Community Oncologists’ Perceptions and Utilization of Large-Panel Genomic Tumor Testing.” BMC Cancer 21 (1): 1273. doi:10.1186/s12885-021-08985-0.
  • Anderson, Eric C., Alexandra Hinton, Christine W. Lary, Tania Strout, Andrey Antov, Emily Edelman, Petra Helbig, Kate Reed, Jens Rueter, and Paul K.J. Han. 2021c. “The Influence of Uncertainty and Uncertainty Tolerance on Attitudes and Self-Efficacy About Genomic Tumor Testing.” Psychology, Health & Medicine 26 (7): 805–817. doi:10.1080/13548506.2020.1764989.
  • Asdal, Kristin, Béatrice Cointe, Bård Hobæk, Hilde Reinertsen, Tone Huse, Silje R. Morsman, and Tommas Måløy. 2021, September. “‘The Good Economy’: A Conceptual and Empirical Move for Investigating How Economies and Versions of the Good Are Entangled.” BioSocieties. doi:10.1057/s41292-021-00245-5.
  • Ball, Jenna, Jeffrey Thompson, Elizabeth Wulff-Burchfield, Edward Ellerbeck, Kim Kimminau, Joanna Veazey Brooks, Shariska Petersen, Duncan Rotich, Anita Y. Kinney, and Shellie D. Ellis. 2020. “Precision Community: A Mixed Methods Study to Identify Determinants of Adoption and Implementation of Targeted Cancer Therapy in Community Oncology.” Implementation Science Communications 1 (1): 72. doi:10.1186/s43058-020-00064-y.
  • Benjamin, Ruha. 2011. “Organized Ambivalence: When Sickle Cell Disease and Stem Cell Research Converge.” Ethnicity & Health 16 (4–5): 447–463. doi:10.1080/13557858.2011.552710.
  • Benjamin, Ruha. 2013. People’s Science: Bodies and Rights on the Stem Cell Frontier. Palo Alto, CA: Stanford University Press.
  • Birch, Kean. 2016. “Rethinking Value in the Bio-Economy: Finance, Assetization, and the Management of Value.” Science, Technology, & Human Values 42 (3): 460–490. doi:10.1177/0162243916661633.
  • Birch, Kean. 2017a. Innovation, Regional Development and the Life Sciences : Beyond Clusters. New York, NY: Routledge.
  • Birch, Kean. 2017b. “Rethinking Value in the Bio-Economy: Finance, Assetization, and the Management of Value.” Science, Technology, & Human Values 42 (3): 460–490. doi:10.1177/0162243916661633.
  • Blake, Kelly D, Jennifer L Moss, Anna Gaysynsky, Shobha Srinivasan, and Robert T Croyle. 2017. “Making the Case for Investment in Rural Cancer Control: An Analysis of Rural Cancer Incidence, Mortality, and Funding Trends.” Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 26 (7): 992–997. doi:10.1158/1055-9965.EPI-17-0092.
  • Bogicevic, Ivana, Kristoffer Staal Rohrberg, Estrid Høgdall, and Mette N. Svendsen. 2020, July. “The Somatic Mode: Doing Good in Targeted Cancer Therapy.” New Genetics and Society, 1–21. doi:10.1080/14636778.2020.1799345.
  • Cambrosio, Alberto, Jonah Campbell, and Pascale Bourret. 2020, December. “Beyond Nosology? Molecular Tumor Boards, Singularization, and the Conflation of Diagnosis and Therapy.” New Genetics and Society, 1–17. doi:10.1080/14636778.2020.1853512.
  • Cambrosio, Alberto, Jonah Campbell, and Pascale Bourret. 2021. “Beyond Nosology? Molecular Tumor Boards, Singularization, and the Conflation of Diagnosis and Therapy.” New Genetics and Society 40 (1): 95–111. doi:10.1080/14636778.2020.1853512.
  • Cambrosio, Alberto, Peter Keating, Etienne Vignola-Gagné, Sylvain Besle, and Pascale Bourret. 2018a. “Extending Experimentation: Oncology’s Fading Boundary Between Research and Care.” New Genetics and Society 37 (3): 207–226. doi:10.1080/14636778.2018.1487281.
  • Cambrosio, Alberto, Etienne Vignola-Gagné, Nicole Nelson, Peter Keating, and Pascale Bourret. 2018b. “Genomic Platforms and Clinical Research .” In Handbook of Genomics, Health and Society. 2nd ed, edited by Sahra Gibbon, Barbara Prainsack, Stephen Hilgartner, and Janelle Lamoreaux, Chapter 18. London: Routledge. https://doi.org/10.4324/9781315451695-18.
  • Charlton, M., J. Schlichting, C. Chioreso, M. Ward, and P. Vikas. 2015. “Challenges of Rural Cancer Care in the United States.” Oncology (Williston Park, N.Y.) 29 (9): 633–640.
  • Charmaz, Kathy. 2014. Constructing Grounded Theory. 2nd ed. London: Sage.
  • Clarke, Adele E. 2005. Situational Analysis: Grounded Theory After the Postmodern Turn. Thousand Oaks, CA: Sage Publications.
  • Clarke, V., V. Braun, G. Terry, and N. Hayfield. 2019. “Thematic Analysis.” In Handbook of Research Methods in Health and Social Sciences, edited by P. Liamputtong, 843–860. Singapore: Springer.
  • Clarke, Adele E., Laura Mamo, Jennifer Ruth Fosket, Jennifer R. Fishman, and Janet K. Shim. 2010. Biomedicalization: Technoscience, Health, and Illness in the U.S. Durham, NC: Duke University Press.
  • Cobain, Erin F., Yi-Mi Wu, Pankaj Vats, Rashmi Chugh, Francis Worden, David C. Smith, Scott M. Schuetze, et al. 2021. “Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors.” JAMA Oncology 7 (4): 525–533.https://doi.org/10.1001/jamaoncol.2020.7987.
  • Cooper, Melinda. 2008. Life as Surplus: Biotechnology and Capitalism in the Neoliberal Era. Seattle, WA: University of Washington Press.
  • Daston, Lorraine. 1995. “The Moral Economy of Science.” Osiris 10 (1): 2–24. doi:10.1086/368740.
  • Datta Burton, Saheli, Katharina Kieslich, Katharina Theresa Paul, Gabrielle Samuel, and Barbara Prainsack. 2021, January. “Rethinking Value Construction in Biomedicine and Healthcare.” BioSocieties. doi:10.1057/s41292-020-00220-6.
  • Dumit, Joseph. 2012. Drugs for Life : How Pharmaceutical Companies Define Our Health. Durham, NC: Duke University Press. http://public.eblib.com/choice/publicfullrecord.aspx?p = 1172262.
  • Dussauge, Isabelle, Claes-Fredrik Helgesson, and Francis 1974- Lee. 2015. Value Practices in the Life Sciences and Medicine. First Edition. 1 Online Resource Vols. Oxford: Oxford University Press. doi:10.1093/acprof:oso/9780199689583.001.0001
  • El-Deiry, Wafik S, Richard M Goldberg, Heinz-Josef Lenz, Anthony F Shields, Geoffrey T Gibney, Antoinette R Tan, Jubilee Brown, et al. 2019. “The Current State of Molecular Testing in the Treatment of Patients with Solid Tumors, 2019.” CA: A Cancer Journal for Clinicians 69 (4): 305–343. doi:10.3322/caac.21560.
  • Fenton, Anny T., Eric C. Anderson, Elizabeth Scharnetzki, Kate Reed, Emily Edelman, Andrey Antov, Jens Rueter, and Paul K.J. Han. 2021. “Differences in Cancer Patients’ and Clinicians’ Preferences for Disclosure of Uncertain Genomic Tumor Testing Results.” Patient Education and Counseling 104 (1): 3–11. doi:10.1016/j.pec.2020.07.010.
  • Fortun, Michael. 2008. Promising Genomics: Iceland and DeCODE Genetics in a World of Speculation. Berkeley, CA: University of California Press.
  • Gardner, Brittany, Michelle Doose, Janeth I. Sanchez, Andrew N. Freedman, and Janet S. de Moor. 2021. “Distribution of Genomic Testing Resources by Oncology Practice and Rurality: A Nationally Representative Study.” JCO Precision Oncology 5 (November): 1060–1068. doi:10.1200/PO.21.00109.
  • Han, Paul K.J., Elizabeth Scharnetzki, Eric Anderson, John DiPalazzo, Tania D. Strout, Caitlin Gutheil, F. Lee Lucas, Emily Edelman, and Jens Rueter. 2021. “Epistemic Beliefs: Relationship to Future Expectancies and Quality of Life in Cancer Patients.” Journal of Pain and Symptom Management Epub Ahead of Print, doi:10.1016/j.jpainsymman.2021.12.017.
  • Jain, Sarah S. Lochlann. [1967] 2013. Malignant : How Cancer Becomes Us. 1 Online Resource (290 Pages) Illustrations Vols. Berkeley, CA: University of California Press. https://www.degruyter.com/isbn/9780520956827.
  • James, Jennifer. 2016. Black Women with Advanced Cancer: An Exploration of Lived Experiences Using Black Feminist Methodology. San Francisco, CA: University of California.
  • Joyce, Kelly Ann, Jennifer Eylse James, and Melanie Jeske. 2020. “Regimes of Patienthood: Developing an Intersectional Concept to Theorize Illness Experiences.” Engaging Science, Technology, and Society 6: 185–192. doi:10.17351/ests2020.389.
  • Kaufman, Sharon R. 2015. Ordinary Medicine : Extraordinary Treatments, Longer Lives, and Where to Draw the Line. Durham, NC: Duke University Press. http://public.eblib.com/choice/publicfullrecord.aspx?p = 2064668.
  • Kenny, Katherine, Alex Broom, Alexander Page, Barbara Prainsack, Claire E Wakefield, Malinda Itchins, Zarnie Lwin, and Mustafa Khasraw. 2021. “A Sociology of Precision-in-Practice: The Affective and Temporal Complexities of Everyday Clinical Care.” Sociology of Health & Illness 43 (9): 2178–2195. doi:10.1111/1467-9566.13389.
  • Kerr, Anne, Julia Swallow, Choon Key Chekar, and Sarah Cunningham-Burley. 2019. “Genomic Research and the Cancer Clinic: Uncertainty and Expectations in Professional Accounts.” New Genetics and Society 38 (2): 222–239. doi:10.1080/14636778.2019.1586525.
  • Knorr-Cetina, Karin, and Werner Reichmann. 2015. “Epistemic Cultures.” In International Encyclopedia of the Social & Behavioral Sciences (Second Edition), edited by James D. Wright, 873–880. Oxford: Elsevier.doi:10.1016/B978-0-08-097086-8.10454-4
  • Kruger, Anne, and Martin Reinhart. 2017. “Theories of Valuation – Building Blocks for Conceptualizing Valuation Between Practice and Structure.” Historical Social Research / Historische Sozialforschung 42 (1): 263–285.
  • Lamont, M. 2012. “Toward a Comparative Sociology of Valuation and Evaluation.” Annual Review of Sociology 38: 201–221.
  • Levit, Laura A., Leslie Byatt, Alan P. Lyss, Electra D. Paskett, Kathryn Levit, Kelsey Kirkwood, Caroline Schenkel, and Richard L. Schilsky. 2020. “Closing the Rural Cancer Care Gap: Three Institutional Approaches.” JCO Oncology Practice 16 (7): 422–430. doi:10.1200/OP.20.00174.
  • Melas, Marilena, Shanmuga Subbiah, Siamak Saadat, Swapnil Rajurkar, and Kevin J McDonnell. 2020. “The Community Oncology and Academic Medical Center Alliance in the Age of Precision Medicine: Cancer Genetics and Genomics Considerations.” Journal of Clinical Medicine 9 (7): 2125. doi:10.3390/jcm9072125.
  • Nadauld, Lincoln D., James M. Ford, Daryl Pritchard, and Thomas Pritchard. 2018. “Strategies for Clinical Implementation: Precision Oncology at Three Distinct Institutions.” Health Affairs 37 (5): 751–756.https://doi.org/10.1377/hlthaff.2017.1575.
  • Nelson, Nicole C., Peter Keating, and Alberto Cambrosio. 2013. “On Being ‘Actionable’: Clinical Sequencing and the Emerging Contours of a Regime of Genomic Medicine in Oncology.” New Genetics & Society 32 (4): 405–428.
  • Phillips, Kathryn A, Julia R Trosman, Patricia A Deverka, Bruce Quinn, Sean Tunis, Peter J Neumann, James D Chambers, Louis P Garrison, Michael P Douglas, and Christine B Weldon. 2018. “Insurance Coverage for Genomic Tests.” Science (New York, N.Y.) 360 (6386): 278–279. doi:10.1126/science.aas9268.
  • Rabeharisoa, Vololona, Pascale Bourret, Alberto Cambrosio, Peter Keating, Thomas Schlich, and George Weisz. 2009. “Staging and Weighting Evidence in Biomedicine: Comparing Clinical Practices in Cancer Genetics and Psychiatric Genetics.” Social Studies of Science 39 (5): 691–715. doi:10.1177/0306312709103501.
  • Schwartzberg, Lee, Edward S. Kim, David Liu, and Deborah Schrag. 2017. “Precision Oncology: Who, How, What, When, and When Not?” American Society of Clinical Oncology Educational Book 37 (May): 160–169. doi:10.1200/EDBK_174176.
  • Spector-Bagdady, Kayte, Chris D Krenz, Collin Brummel, J. Chad Brenner, Carol R Bradford, and Andrew G Shuman. 2020. “‘My Research Is Their Business, but I’m Not Their Business’: Patient and Clinician Perspectives on Commercialization of Precision Oncology Data.” The Oncologist 25 (7): 620–626. doi:10.1634/theoncologist.2019-0863.
  • Sunder Rajan, Kaushik. 2012. Lively Capital : Biotechnologies, Ethics, and Governance in Global Markets. Experimental Futures. Durham, NC: Duke University Press.
  • Swallow, Julia, Anne Kerr, Choon Key Chekar, and Sarah Cunningham-Burley. 2020. “Accomplishing an Adaptive Clinical Trial for Cancer: Valuation Practices and Care Work Across the Laboratory and the Clinic.” Social Science & Medicine 252 (May): 112949. doi:10.1016/j.socscimed.2020.112949.
  • Thompson, Charis. 2013. “Good Science : The Ethical Choreography of Stem Cell Research.”
  • Underman, Kelly, and Laura E. Hirshfield. 2016. “Detached Concern?: Emotional Socialization in Twenty-First Century Medical Education.” Social Science & Medicine 160 (July): 94–101. doi:10.1016/j.socscimed.2016.05.027.
  • Vinson, Alexandra H., and Kelly Underman. 2020. “Clinical Empathy as Emotional Labor in Medical Work.” Social Science & Medicine 251 (April): 112904. doi:10.1016/j.socscimed.2020.112904.
  • Weatherford Darling, Katherine, Angie M. Boyce, Mildred K. Cho, and Pamela L. Sankar. 2015. “What Is the FDA Going to Think? : Negotiating Values Through Reflective and Strategic Category Work in Microbiome Science.” Science, Technology, & Human Values 40 (1): 71–95.
  • Whitmarsh, Ian. 2008. Biomedical Ambiguity Race, Asthma, and the Contested Meaning of Genetic Research in the Caribbean. 1st ed. 240 Vols. London: Cornell University Press.
  • Yabroff, K. Robin, Xuesong Han, Jingxuan Zhao, Leticia Nogueira, and Ahmedin Jemal. 2020. “Rural Cancer Disparities in the United States: A Multilevel Framework to Improve Access to Care and Patient Outcomes.” JCO Oncology Practice 16 (7): 409–413. doi:10.1200/OP.20.00352.
  • Zehir, Ahmet, Ryma Benayed, Ronak H. Ronak, Aijazuddin Shah, Sumit Middha, Hyunjae R. Kim, Preethi Srinivasan, et al. 2017. “Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients.” Nature Medicine 23 (6): 703–713.https://doi.org/10.1038/nm.4333.
  • Ziller, Erika. 2015. “Access to Medical Care in Rural America.” In Rural Public Health : Best Practices and Preventive Models, edited by Jacob C. Warren and K. Bryant Smalley, Chapter 2. New York, NY: Springer Publishing Company.